DB
Dilip Bakhtawar Ranka
About Dilip Bakhtawar Ranka
Data last updated:
Dilip Bakhtawar Ranka is a Whole-Time Director at Western Drugs Limited (since 2015), Additional Director at G.G.Valves Private Limited (since 2026) and Director at Ranka Organics Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Healthcare, Machinery and Equipment and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹317 Cr; the largest is Western Drugs Limited at ₹236 Cr (FY 2025). Earlier, Dilip Bakhtawar Ranka was a Partner at Transmissions Limited Liability Partnership (from 2013) and Director at Transmissions Private Limited (from 1989).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 02 Mar 2015 | 1989 | ₹236 Cr (FY 2025) | Active | |
| Additional Director | 20 Aug 2026 | 1984 | ₹68.85 Cr (FY 2024) | Active | |
| Director | 27 Sep 2011 | 1998 | ₹12.67 Cr (FY 2024) | Active | |
| Partner | 23 Aug 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 10 May 2013 | 2013 | Strike Off | ||
| Director | 01 Jul 1989 | 1957 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dilip Bakhtawar Ranka
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankita Agrawal | 10807423 | Western Drugs Limited | Director |
| Bhagwati Lal Dagliya | 00302082 | Western Drugs Limited , Ranka Organics Private Limited | Managing Director |
| Jayantilal Ranka | 00361466 | Western Drugs Limited | Director |
| Mahavir Ranka | 00337553 | Western Drugs Limited , Ranka Organics Private Limited | Whole-Time Director |
| Mishri Lal Lodha | 00302054 | Western Drugs Limited , Ranka Organics Private Limited | Whole-Time Director |
| Neha Bapna | 08660157 | Western Drugs Limited | Director |
| Sanjay Ranka | 00361378 | G.G.Valves Private Limited | Managing Director |
| Bakhtawar Chunilal Ranka | 00574915 | Global Translloy Metal Limited Liability Partnership | Designated Partner |
| Manish Jayantilal Ranka | 00574827 | Global Translloy Metal Limited Liability Partnership | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilip Bakhtawar Ranka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilip Bakhtawar Ranka
Dilip Bakhtawar Ranka currently holds 4 directorships: Western Drugs Limited (Whole-Time Director, since 02 Mar 2015, revenue ₹236 Cr (FY 2025)); G.G.Valves Private Limited (Additional Director, since 20 Aug 2026, revenue ₹68.85 Cr (FY 2024)); Ranka Organics Private Limited (Director, since 27 Sep 2011, revenue ₹12.67 Cr (FY 2024)); Global Translloy Metal Limited Liability Partnership (Partner, since 23 Aug 2016).
Dilip Bakhtawar Ranka was first appointed on 01 Jul 1989 as Director at Transmissions Private Limited. The most recent appointment on record is 20 Aug 2026 at G.G.Valves Private Limited.
The 3 current companies of Dilip Bakhtawar Ranka that report revenue have a combined latest revenue of ₹317 Cr: Western Drugs Limited ₹236 Cr (FY 2025); G.G.Valves Private Limited ₹68.85 Cr (FY 2024); Ranka Organics Private Limited ₹12.67 Cr (FY 2024).
Dilip Bakhtawar Ranka held 2 earlier board appointments: Transmissions Limited Liability Partnership (Partner, from 10 May 2013); Transmissions Private Limited (Director, from 01 Jul 1989).
The current boards of Dilip Bakhtawar Ranka's companies include Ankita Agrawal (Western Drugs Limited), Bhagwati Lal Dagliya (Western Drugs Limited), Jayantilal Ranka (Western Drugs Limited), Mahavir Ranka (Western Drugs Limited), Mishri Lal Lodha (Western Drugs Limited), Neha Bapna (Western Drugs Limited), among others.